Bio-Rad Laboratories, Inc. (BIO) income statement
BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3067% above fair value
$358.90−8.60 (-2.34%)
Close on Nov 20, 2026Market cap $9.60BP/E 43.5Yield –
Bio-Rad Laboratories, Inc. financial ratios
See a number that looks wrong?